Midwood Group | Matrix Immunology
Research Group, Kennedy Institute
BSc (Hons), PhD
Professor of Matrix Biology
Professor Kim Midwood graduated with a B.Sc. (HONS) in Biochemistry from Edinburgh University in 1995. She completed her Ph.D. in the Department of Pathology at Edinburgh University in 1999, focusing on how changes in the extracellular matrix affect cellular signalling pathways in arthritis. She undertook postdoctoral training in the lab of Professor Jean Schwarzbauer, at Princeton University from 1999, continuing her work investigating the molecular mechanisms by which the cellular environment defines cell phenotype.
In 2004 she established the Matrix Immunology group in the Kennedy Institute of Rheumatology at Imperial College London, moving to Oxford University in 2011.
In 2007 she won an MRC New Investigators Award and in 2012 an Arthritis Research UK Senior Fellowship.
She founded the BioTech company Nascient Ltd in 2012.
Tenascin-C is a driver of inflammation in the DSS model of colitis
MIDWOOD KIM., (2022), Matrix Biology Plus
FAS2FURIOUS: Moderate-throughput secreted expression of difficult recombinant proteins in Drosophila S2 cells
MIDWOOD KIM. et al, (2022), Frontiers in Bioengineering and Biotechnology, section Synthetic Biology
Tenascin-C in fibrosis in multiple organs: translational implications
MIDWOOD KIM. et al, (2022), Seminars in Cell and Developmental Biology
Tenascins: key players in tissue homeostasis and defence
Midwood K., (2022), Frontiers in Immunology
Editorial: Tenascins - Key Players in Tissue Homeostasis and Defense
MIDWOOD KIM., (2022), Frontiers in Immunology